Description Proton pump inhibitors (PPIs) are among the most commonly used medications
in the world. Developed for the treatment and prevention of acid-mediated upper …

Importance Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory
disease of the esophagus that affects an estimated 34.4/100 000 people in Europe and …

Background & Aims Over the last decade, clinical experiences and research studies raised
concerns regarding use of proton pump inhibitors (PPIs) as part of the diagnostic strategy for …

Background Eosinophilic oesophagitis (EoE) is an increasingly common cause of dysphagia
in both children and adults, as well as one of the most prevalent oesophageal diseases with …

Eosinophilic esophagitis (EoE) has emerged over the past 2 decades as a major cause of
upper gastrointestinal morbidity. Over this time, the epidemiology of EoE has also rapidly …

Background & Aims Swallowed topical-acting corticosteroids are recommended as first-line
therapy for eosinophilic esophagitis (EoE). Asthma medications not optimized for …

Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

Background Numerous dietary restrictions and endoscopies limit the implementation of
empiric elimination diets in patients with eosinophilic esophagitis (EoE). Milk and …

Рос журн гастроэнтерол гепатол колопроктол 2018; 28 (3)/Rus J Gastroenterol Hepatol
Coloproctol 2018; 28 (3) путей и вторичным нарушением сократимости; возможно …

Consensus diagnostic recommendations to distinguish GORD from eosinophilic
oesophagitis (EoE) by response to a trial of proton pump inhibitors (PPIs) unexpectedly …